Interferon beta-1a SubQ injection Treatment Report

Category: Prescription Drugs

Most Popular Types: Rebif

false

What is Interferon beta-1a SubQ injection?

An example of Interferon beta-1a SubQ injection

Interferon beta-1a is an immunomodulator used to prevent episodes of symptoms and slow the development of disability in patients with relapsing-remitting multiple sclerosis. It comes as a solution to inject subcutaneously (under the skin) three times a week, ideally the same 3 days each week.

Reported Purpose & Perceived Effectiveness

Reasons and Perceived effectiveness
Perceived Effectiveness
Purpose # of patients # of patients with evaluations
Major
Moderate
Slight
None
Can’t tell
2,589 785 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
28 6 Efficacy_moderate Efficacy_none Efficacy_cant_tell
21 3 Efficacy_none Efficacy_cant_tell
16 9 Efficacy_major Efficacy_slight Efficacy_none Efficacy_cant_tell
9 4 Efficacy_major Efficacy_moderate Efficacy_slight
4 2 Efficacy_moderate Efficacy_cant_tell

See all 1,948 patients currently taking Interferon beta-1a SubQ injection

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
166
Moderate
269
Mild
289
None
98

Commonly reported side effects, conditions, and hospitalizations associated with Interferon beta-1a SubQ injection

179
151
151
131
104
96
See all 251 reported side effects See top 6 reported side effects

Reported Dosages

Frequently reported dosages based on patients currently taking Interferon beta-1a SubQ injection. See all 152 dosages

  3 times a week 44 mcg/0.5 mL weekly 22 mcg/0.5 mL 3 times a week 30 mcg/0.5 mL 3 times a week 44 mcg 44 mcg/0.5 mL 3 times a week 44 mcg/0.5 mL m,w,f 3 x 44 mcg/0.5 mL weekly 44 mg 44 mcg/0.5 mL daily
  141 Number of Patients: 141 53 Number of Patients: 53 164 Number of Patients: 164 41 Number of Patients: 41 77 Number of Patients: 77 767 Number of Patients: 767 44 Number of Patients: 44 155 Number of Patients: 155 67 Number of Patients: 67 70 Number of Patients: 70  

Reported Stop Reasons

Why Patients Stopped Taking Interferon beta-1a SubQ injection (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 607   Side effects too severe: 48%
Did not seem to work 398   Did not seem to work: 31%
Doctor's advice 345   Doctor's advice: 27%
Other 236   Other: 18%
Expense 68   Expense: 5%
Personal research 53   Personal research: 4%
Not indicated 29   Not indicated: 2%
Course of treatment ended 23   Course of treatment ended: 2%
Change in health plan coverage 22   Change in health plan coverage: 2%

See all 1233 patients who’ve stopped taking Interferon beta-1a SubQ injection

Currently Taking Interferon beta-1a SubQ injection

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Stopped Taking Interferon beta-1a SubQ injection

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Interferon beta-1a SubQ injection

Always
636 77%
Usually
140 17%
Sometimes
21 3%
Never
25 3%

Burden

Difficulty being on treatment

Burden of Interferon beta-1a SubQ injection

Very
110 13%
Somewhat
225 27%
A little
275 33%
Not at all
212 26%

Cost

Paid out of pocket

Cost of Interferon beta-1a SubQ injection

$200+
54 9%
$100-199
31 5%
$50-99
142 23%
$25-49
152 25%
< $25
232 38%

Sort by: Helpfulness | Most Recent

122 patient evaluations for Interferon beta-1a SubQ injection

Purpose: MS (Multiple Sclerosis) (Started Aug 15, 2011)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Mar 20, 2013 44 mcg/0.5 mL M,W,F Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_defaultModerate ModerateModerateModerateModerateModerate AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
Jun 05, 2012 44 mcg/0.5 mL M,W,F ?Can't tell MildMildMildMildMild AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
Date
Jun 05, 2012
Advice & Tips
I do my shots in the morning. I have found that the site reaction is very little, I sleep better at nite. Just easier to manage.
Cost
< $25 monthly
  • Icon_thumb_off 0 helpful marks
Purposes: MS (Multiple Sclerosis) and General health (Started Feb 14, 2008)
Date Dosage MS (Multiple Sclerosis) Perceived effectiveness General health Perceived effectiveness Side Effects Adherence Burden
Jan 09, 2013 44 mcg 3 times a week Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_defaultModerate Led_efficacy_2Led_efficacy_2Led_defaultLed_defaultSlight ModerateModerateModerateModerateModerate AlwaysAlwaysAlwaysAlwaysAlways SomewhatSomewhatSomewhatSomewhatSomewhat
Jul 27, 2009 44 mcg 3 times a week Led_efficacy_2Led_efficacy_2Led_defaultLed_defaultSlight MildMildMildMildMild AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
Apr 07, 2009 44 mcg 3 times a week Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major ModerateModerateModerateModerateModerate AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
Side effects:
Dizziness, Injection site itching, Generalized muscle aches, Injection site redness, Injection site burning, Headaches, Injection site pain, Optic nerve inflammation (Optic neuritis)
Date
Jan 09, 2013
Advice & Tips
I'm so over these shots but Don't think I can get into anything else any time soon. My goal is to be off Rebif in 2013... I hope.
Cost
$50-99 monthly
Date
Apr 07, 2009
Advice & Tips
Looking back over the last year I have had some ups and downs but over all I feel very lucky to have started treatment so quickly. I feel better everyday and if I have to deal with minor dizzy spells from time to time, so be it. I hope next year when I update my profile and can report even more progress.
Cost
< $25 monthly
  • Icon_thumb_off 0 helpful marks
Purpose: MS (Multiple Sclerosis) (Started Nov 01, 2009)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Sep 15, 2012 44 mcg/0.5 mL 3 times a week Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_defaultModerate ModerateModerateModerateModerateModerate NeverNeverNeverNeverNever Not at allNot at allNot at allNot at allNot at all
  • Icon_thumb_off 0 helpful marks
1 2 3 4 5 6 ... 41    You are at the first page First There is no previous page Prev | Next Go to the next page Last Go to the last page 

What is interferon beta-1a?

Interferon beta-1a is made from human proteins. Interferons help the body fight viral infections.

Interferon beta-1a is used to treat relapsing multiple sclerosis (MS). This medication will not cure MS, it will only decrease the frequency of relapse symptoms.

Interferon beta-1a may also be used for other purposes not listed in this medication guide.


Precautions

Do not use this medication if you are allergic to interferons or human albumin.

Some patients using interferon medications have become very depressed or had thoughts of suicide. Stop using interferon beta-1a if you have symptoms of depression (sadness, crying, loss of interest in things you once liked) or if you have any thoughts of hurting yourself.

Before using interferon beta-1a, tell your doctor if you are allergic to any drugs, or if you have:

  • liver disease;
  • epilepsy or other seizure disorder;
  • heart disease, chest pain (angina), congestive heart failure, or a heart rhythm disorder;
  • a thyroid disorder; or
  • a history of depression or suicidal behavior.

If you have any of these conditions, you may need a dose adjustment or special tests to safely use interferon beta-1a.

FDA pregnancy category C. This medication may be harmful to an unborn baby, or may cause a miscarriage. Do not use interferon beta-1a if you are pregnant. Tell your doctor if you become pregnant during treatment.

It is not known whether interferon beta-1a passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

Interferon beta-1a is made from human plasma (part of the blood) and may contain viruses and other infectious agents that can cause disease. Although donated human plasma is screened, tested, and treated to reduce the risk of it containing anything that could cause disease, there is still a small possibility it could transmit disease. Talk with your doctor about the risks and benefits of using this medication.

Avoid drinking alcohol while using interferon beta-1a. Alcohol may increase your risk of liver damage.

Interferons can lower the blood cells that help your body fight infections. This can make it easier for you to bleed from an injury or get sick from being around others who are ill. Avoid being near people who have colds, the flu, or other contagious illnesses. Contact your doctor at once if you develop signs of infection.

Back to top

Instructions

Seek emergency medical attention if you think you have used too much of this medicine. Symptoms of an interferon beta-1a overdose are not known.

Call your doctor for instructions if you miss a dose of this medication.

Back to top

Side Effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have a serious side effect such as:

  • depressed mood, anxiety, trouble sleeping, restlessness, or thoughts of suicide or hurting yourself;
  • easy bruising or bleeding, weakness;
  • seizure (convulsions);
  • numbness or tingling in your hands or feet;
  • pain or burning when you urinate;
  • pain, swelling, or skin changes where the injection was given;
  • fever, chills, body aches, flu symptoms; or
  • nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).

Less serious side effects may include:

  • headache, dizziness;
  • stomach pain; or
  • runny or stuffy nose.

This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.

Back to top

Interactions

Interferon beta-1a can be harmful to your liver, and these effects are increased when interferon beta-1a is used together with other medicines that can harm the liver. Before using this medication, tell your doctor if you are also using:

  • acetaminophen (Tylenol);
  • cancer medications;
  • tuberculosis medications;
  • birth control pills or hormone replacement therapy;
  • methotrexate (Rheumatrex, Trexall);
  • arthritis medications such as auranofin (Ridaura) or aurothioglucose (Solganol);
  • an antibiotic;
  • HIV/AIDS medications;
  • cholesterol medications such atorvastatin (Lipitor), simvastatin (Zocor), and others;
  • an ACE inhibitor such as benazepril (Lotensin), captopril (Capoten), lisinopril (Prinivil, Zestril), and others;
  • an NSAID (non-steroidal anti-inflammatory drug) such as ibuprofen (Motrin, Advil), naproxen (Aleve, Naprosyn), indomethacin (Indocin), and others; or
  • seizure medications such as carbamazepine (Carbatrol, Tegretol), phenytoin (Dilantin), or valproic acid (Depakene).

This list is not complete and there may be other drugs that can interact with interferon beta-1a. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.

Other Names

Avonex, Avonex Prefilled Syringe, Rebif, and interferon beta-1a

Available Strengths & Dosages


Route Form Strength
subcutaneous solution 44 mcg/0.5 mL
subcutaneous solution 22 mcg/0.5 mL
subcutaneous kit -

Back to top

Disclaimer

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2004 Cerner Multum, Inc. Version 2.05. Revision date 8/23/04

Last updated: